✦ LIBER ✦

Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone as First-Line Therapy for Multiple Myeloma

✍ Scribed by Hussein, Mohamad

Book ID: 119935780
Publisher: CIG Media Group, LP.
Year: 2003
Tongue: English
Weight: 134 KB
Volume: 4
Category: Article
ISSN: 1526-9655
DOI: 10.3816/clm.2003.s.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of pegylated liposomal

A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients

✍ Mohamad A. Hussein; Laura Wood; Eric Hsi; Gordan Srkalovic; MaryAnn Karam; Paul 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract ## BACKGROUND Patients with multiple myeloma (MM) have increased bone marrow angiogenesis, a low plasma cell labeling index, and multidrug resistance (the primary cause of chemotherapy failure). MM patients receiving the vincristine, doxorubicin, and dexamethasone (VAD) regimen develop

INFUSION OF VINCRISTINE AND DOXORUBICIN

INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA

✍ Newland, Adrian; Kearney, Joseph; Joyner, Miles; Mitchell, Terry; Barrett, A.Joh 📂 Article 📅 1989 🏛 The Lancet 🌐 English ⚖ 545 KB

An open-label study of pegylated liposom

An open-label study of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients in the Chinese population

✍ Yang Shen; Zhixiang Shen; Bin Jiang; Jian Hou; Rong Zhan; Lugui Qiu; Daobin Zhou 📂 Article 📅 2009 🏛 Springer-Verlag ⚖ 370 KB

Vincristine, doxorubicin and dexamethaso

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma

✍ C. M. Segeren; P. Sonneveld; B. Van Der Holt; J. W. Baars; D. H. Biesma; J. J. C 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Weekly Bortezomib, Pegylated Liposomal D

Weekly Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone Is a Safe and Effective Therapy for Elderly Patients With Relapsed/Refractory Multiple Myeloma

✍ Alessandro Gozzetti; Alberto Fabbri; Stefania Oliva; Elena Marchini; Monica Bocc 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 115 KB

Pegylated Liposomal Doxorubicin and Cycl

Pegylated Liposomal Doxorubicin and Cyclophosphamide as First-Line Therapy for Patients with Metastatic or Recurrent Breast Cancer

✍ Beth Overmoyer; Paula Silverman; Larry W. Holder; Debasish Tripathy; I. Craig He 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 493 KB